Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Longboard Pharmaceuticals Inc
(NQ:
LBPH
)
37.27
+2.48 (+7.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,151,148
Open
35.40
Bid (Size)
37.00 (1)
Ask (Size)
37.99 (1)
Prev. Close
34.79
Today's Range
34.48 - 37.64
52wk Range
3.600 - 40.48
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Longboard Pharmaceuticals to Present Late-Breaking and Encore Data at the 15th European Epilepsy Congress
August 26, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Host Investor & Analyst Event in New York on September 16, 2024
August 26, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Performance
YTD
+48.49%
+48.49%
1 Month
+6.85%
+6.85%
3 Month
+99.73%
+99.73%
6 Month
+62.18%
+62.18%
1 Year
+529.56%
+529.56%
More News
Read More
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
August 02, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Recap: Longboard Pharmaceuticals Q4 Earnings
March 12, 2024
Via
Benzinga
Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
August 01, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Report Second Quarter 2024 Financial Results and Host Corporate Update Call on August 1
July 29, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
3 Russell 2000 Growth Stocks That Could Be Worth the Risk
July 23, 2024
Via
The Motley Fool
Topics
Economy
Exposures
Interest Rates
Looking Into Longboard Pharmaceuticals's Recent Short Interest
January 19, 2024
Via
Benzinga
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
July 03, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Top 3 Health Care Stocks That May Crash This Quarter
July 03, 2024
Via
Benzinga
Longboard Pharmaceuticals Receives Breakthrough Therapy Designation for Bexicaserin (LP352)
July 01, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Announces Positive Interim Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies (DEEs)
June 10, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
June 03, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
May 06, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
LBPH Stock Earnings: Longboard Pharmaceuticals Beats EPS for Q1 2024
May 02, 2024
Via
InvestorPlace
Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
May 02, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
April 03, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
April 02, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
March 12, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
March 01, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
February 02, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February
February 01, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Forget the "Magnificent Seven" -- This Stock Has Nearly Quadrupled in 2024, and Wall Street Thinks It Can Go a Lot Higher
January 17, 2024
Via
The Motley Fool
Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 26, 2024
Via
Benzinga
Cantor Fitzgerald Maintains Overweight Rating for Longboard Pharmaceuticals: Here's What You Need To Know
January 16, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.